Minnesota Leads the Nation in Congenital CMV: Building the Case for Universal Newborn Screening

In February of 2022 Minnesota became the first state in the U.S. to require the screening for every newborn for congenital CMV. This was the first infectious disease added to the newborn screening panel which historically has only focused on inherited genetic conditions.  This webinar will discuss the importance of congenital CMV universal screening and introduce how Minnesota plans to realize this goal.

 

 

Objectives:

 

Outline importance of congenital CMV.

Discuss universal screening and impact on newborn healthcare.

Review discussions about development of an implementation plan for universal congenital CMV screening in Minnesota.

 

Learning Objectives:

 

Introduce congenital CMV (transmission, clinical presentation, complications of infection, diagnosis and treatment).

Discuss universal screening and impact.

Discuss initial steps toward development of an implementation plan for universal screening.

Current vaccine status update.